KR102632228B1 - 벤즈아제핀 유도체 - Google Patents

벤즈아제핀 유도체 Download PDF

Info

Publication number
KR102632228B1
KR102632228B1 KR1020207002409A KR20207002409A KR102632228B1 KR 102632228 B1 KR102632228 B1 KR 102632228B1 KR 1020207002409 A KR1020207002409 A KR 1020207002409A KR 20207002409 A KR20207002409 A KR 20207002409A KR 102632228 B1 KR102632228 B1 KR 102632228B1
Authority
KR
South Korea
Prior art keywords
alkyl
optionally substituted
ring
mixture
added
Prior art date
Application number
KR1020207002409A
Other languages
English (en)
Korean (ko)
Other versions
KR20200020910A (ko
Inventor
게이조 간
마사토시 다쿠와
히로타카 다나카
히데토 후지와라
호쿠토 야마베
사토시 마츠다
가즈히로 오다치
다이키 하나리
야스히로 멘조
다츠야 우루시마
시게카즈 후지타
Original Assignee
오츠카 세이야쿠 가부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 오츠카 세이야쿠 가부시키가이샤 filed Critical 오츠카 세이야쿠 가부시키가이샤
Publication of KR20200020910A publication Critical patent/KR20200020910A/ko
Application granted granted Critical
Publication of KR102632228B1 publication Critical patent/KR102632228B1/ko

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16Benzazepines; Hydrogenated benzazepines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
KR1020207002409A 2017-06-30 2018-06-29 벤즈아제핀 유도체 KR102632228B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/JP2017/024211 WO2019003433A1 (ja) 2017-06-30 2017-06-30 ベンゾアゼピン誘導体
JPPCT/JP2017/024211 2017-06-30
PCT/JP2018/024786 WO2019004421A1 (en) 2017-06-30 2018-06-29 BENZAZEPINE DERIVATIVES

Publications (2)

Publication Number Publication Date
KR20200020910A KR20200020910A (ko) 2020-02-26
KR102632228B1 true KR102632228B1 (ko) 2024-02-02

Family

ID=62976113

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020207002409A KR102632228B1 (ko) 2017-06-30 2018-06-29 벤즈아제핀 유도체

Country Status (24)

Country Link
US (3) US10889570B2 (de)
EP (2) EP4056557B1 (de)
JP (2) JP6688436B2 (de)
KR (1) KR102632228B1 (de)
CN (1) CN110891939A (de)
AU (1) AU2018293081B2 (de)
BR (1) BR112019027678A2 (de)
CA (1) CA3068396A1 (de)
DK (2) DK4056557T3 (de)
EA (1) EA202090131A1 (de)
ES (2) ES2964569T3 (de)
FI (1) FI4056557T3 (de)
HR (2) HRP20231616T1 (de)
HU (2) HUE060855T2 (de)
IL (1) IL271665B2 (de)
LT (2) LT4056557T (de)
PH (1) PH12020500034A1 (de)
PL (2) PL3645513T3 (de)
PT (2) PT4056557T (de)
SA (1) SA519410888B1 (de)
SG (1) SG11201912757VA (de)
SI (1) SI4056557T1 (de)
TW (1) TWI798234B (de)
WO (2) WO2019003433A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6868089B2 (ja) * 2018-12-28 2021-05-12 大塚製薬株式会社 医薬
CA3160645A1 (en) * 2019-11-07 2021-05-14 The Board Of Trustees Of The University Of Illinois Inhibitors of influenza viral entry
CN111450879A (zh) * 2020-05-08 2020-07-28 内蒙古自治区石油化工监督检验研究院 用于乙炔氢氯化反应的丙二胺改性低钌催化剂及制备方法
CN116472271A (zh) * 2020-11-26 2023-07-21 上海济煜医药科技有限公司 新型苯并氮杂卓螺环衍生物

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5985869A (en) * 1989-10-20 1999-11-16 Otsuka Pharmaceutical Company, Limited Benzoheterocyclic compounds
JP2905909B2 (ja) 1991-04-19 1999-06-14 大塚製薬株式会社 バソプレシン拮抗剤
US5258510A (en) * 1989-10-20 1993-11-02 Otsuka Pharma Co Ltd Benzoheterocyclic compounds
EP0450097B1 (de) 1989-10-20 1996-04-24 Otsuka Pharmaceutical Co., Ltd. Benzoheterozyklische verbindungen
WO1994001113A1 (en) 1992-07-02 1994-01-20 Otsuka Pharmaceutical Company, Limited Oxytocin antagonist
JP2961291B2 (ja) * 1992-08-20 1999-10-12 大塚製薬株式会社 ベンゾヘテロ環化合物
EP0612319A1 (de) 1992-08-20 1994-08-31 Otsuka Pharmaceutical Co., Ltd. Benzoheterocyclische verbindungen als oxytocin antagonisten und vasopressinantagonisten.
TW270927B (de) 1992-10-16 1996-02-21 Otsuka Pharma Co Ltd
JP2913082B2 (ja) * 1992-10-16 1999-06-28 大塚製薬株式会社 バソプレシン拮抗剤及びオキシトシン拮抗剤
EP0716083A4 (de) 1993-08-26 1996-08-28 Yamanouchi Pharma Co Ltd Benzazepin-derivate, diese enthaltende pharmazeutische präparate sowie zwischen-produkte zur herstellung
DE69530690T2 (de) 1994-06-15 2004-03-18 Otsuka Pharmaceutical Co., Ltd. Benzoheterocyclische derivate verwendbar als vasopressin- oder oxytocin-modulatoren
JPH09221476A (ja) 1995-12-15 1997-08-26 Otsuka Pharmaceut Co Ltd 医薬組成物
JPH10120592A (ja) 1996-10-22 1998-05-12 Otsuka Pharmaceut Co Ltd メニエール病乃至メニエール症候群治療剤
AUPP150098A0 (en) 1998-01-27 1998-02-19 Fujisawa Pharmaceutical Co., Ltd. Benzamide derivatives
JP4374088B2 (ja) * 1999-01-14 2009-12-02 東ソ−・エフテック株式会社 新規な4,4−ジフルオロベンゾアゼピンケタール誘導体、およびそれを経由する4,4−ジフルオロベンゾアゼピン−5−オン誘導体の製造方法
EP1627876A1 (de) 2004-08-20 2006-02-22 Ferring B.V. Kondensierte heterocyclische Verbindungen und ihre Verwendung als antidiuretische Mittel
TWI459947B (zh) * 2007-06-26 2014-11-11 Otsuka Pharma Co Ltd 苯并氮呯化合物及藥學製劑
WO2011052519A1 (ja) * 2009-10-26 2011-05-05 大塚製薬株式会社 ベンズアゼピン化合物
US8025813B2 (en) 2009-11-12 2011-09-27 Rohm And Haas Electronic Materials Cmp Holdings, Inc. Chemical mechanical polishing composition and methods relating thereto
JP2016513112A (ja) * 2013-02-18 2016-05-12 ザ スクリプス リサーチ インスティテュート 治療的潜在能力を有するバソプレッシン受容体のモジュレーター
TW201605488A (zh) 2013-10-15 2016-02-16 大塚製藥股份有限公司 用以預防及/或治療多囊腎病之藥物

Also Published As

Publication number Publication date
EP3645513A1 (de) 2020-05-06
ES2964569T3 (es) 2024-04-08
US10889570B2 (en) 2021-01-12
CN110891939A (zh) 2020-03-17
SI4056557T1 (sl) 2024-02-29
IL271665B1 (en) 2023-01-01
US20210078976A1 (en) 2021-03-18
JP7055160B2 (ja) 2022-04-15
PL3645513T3 (pl) 2022-12-19
HRP20221359T1 (hr) 2023-01-06
PT3645513T (pt) 2022-11-16
SA519410888B1 (ar) 2023-03-15
EA202090131A1 (ru) 2020-04-14
US20190389838A1 (en) 2019-12-26
JP2020117525A (ja) 2020-08-06
JP6688436B2 (ja) 2020-04-28
SG11201912757VA (en) 2020-01-30
HUE060855T2 (hu) 2023-04-28
CA3068396A1 (en) 2019-01-03
KR20200020910A (ko) 2020-02-26
BR112019027678A2 (pt) 2020-09-15
EP4056557B1 (de) 2023-11-22
DK3645513T3 (da) 2022-11-14
FI4056557T3 (fi) 2023-12-14
US20230265073A1 (en) 2023-08-24
HUE065010T2 (hu) 2024-04-28
EP3645513B1 (de) 2022-10-05
IL271665A (en) 2020-02-27
US11673878B2 (en) 2023-06-13
PL4056557T3 (pl) 2024-04-08
WO2019003433A1 (ja) 2019-01-03
IL271665B2 (en) 2023-05-01
TWI798234B (zh) 2023-04-11
WO2019004421A1 (en) 2019-01-03
PT4056557T (pt) 2023-12-15
ES2932854T3 (es) 2023-01-27
DK4056557T3 (da) 2023-12-18
HRP20231616T1 (hr) 2024-03-15
PH12020500034A1 (en) 2020-09-14
EP4056557A1 (de) 2022-09-14
TW201904946A (zh) 2019-02-01
AU2018293081B2 (en) 2021-11-25
LT4056557T (lt) 2023-12-27
JP2020503346A (ja) 2020-01-30
LT3645513T (lt) 2022-11-25
AU2018293081A1 (en) 2019-12-19

Similar Documents

Publication Publication Date Title
KR102632228B1 (ko) 벤즈아제핀 유도체
CA2930754C (en) Pyrazolopyridine derivatives as modulators of tnf activity
RU2684644C1 (ru) Производные пурина в качестве модуляторов активности tnf
SK285432B6 (sk) Disubstituované bicyklické heterocyklické zlúčeniny, spôsob ich výroby, farmaceutický prostriedok sich obsahom a ich použitie
CA2943824A1 (en) Inhibitors of histone demethylases
EP2065381A1 (de) CGRP Antagonisten
EP1256576A1 (de) Kondensierte imidazolderivate
JP2017508777A (ja) ROS1阻害剤としての置換4,5,6,7−テトラヒドロ−ピラゾロ[1,5−a]ピリミジン誘導体および2,3−ジヒドロ−1H−イミダゾ[1,2−b]ピラゾール誘導体
US20200377510A1 (en) Derivatives of piperlongumine and uses thereof
JP5717645B2 (ja) ベンズアゼピン化合物
CA3085874A1 (en) Substituted pyrrolidine amides i
WO1995023147A1 (fr) Compose heterocyclique
JP7462589B2 (ja) 医薬組成物
EP2781508B9 (de) Stickstoffhaltige kondensierte ringverbindungen zur verwendung als crth2-antagonisten
EA040222B1 (ru) Производные бензазепина
WO2023230542A2 (en) PYRAZOLO[1,5-a]PYRIDINE DERIVATIVES FOR TREATING TRPM3-MEDIATED DISORDERS
WO2021129629A1 (zh) Zeste增强子同源物2抑制剂及其用途

Legal Events

Date Code Title Description
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant